2023
DOI: 10.1111/poms.13973
|View full text |Cite
|
Sign up to set email alerts
|

“Not a box of nuts and bolts”: Distribution channels for specialty drugs

Abstract: One of the most important trends in the pharmaceutical industry is the rapid growth of specialty drugs. Specialty drugs, mostly bio based, tend to be high risk, high priced, and more regulated than traditional drugs, resulting in unprecedented challenges in distribution. Such challenges lead to the emergence of specialty distributors (SDs), which, compared with traditional wholesalers (WSs), represent a more controlled channel and carry a smaller variety of drugs. Due to the risky nature of specialty drugs, ma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 43 publications
0
2
0
Order By: Relevance
“…Trade partners can be categorized as “traditional wholesalers” and “specialty distributors.” The former typically have large networks, carry a large variety of drugs, and more often distribute to hospitals, retail pharmacies, and homecare providers, while the latter typically have more controlled networks, specialize in specialty drugs and more often distribute to physician offices, clinics, and independent specialty pharmacies (Xu et al. 2018). Regardless of its type, each TP has its own network of DCs, through which POCs receive the drugs.…”
Section: Literature Reviewmentioning
confidence: 99%
See 1 more Smart Citation
“…Trade partners can be categorized as “traditional wholesalers” and “specialty distributors.” The former typically have large networks, carry a large variety of drugs, and more often distribute to hospitals, retail pharmacies, and homecare providers, while the latter typically have more controlled networks, specialize in specialty drugs and more often distribute to physician offices, clinics, and independent specialty pharmacies (Xu et al. 2018). Regardless of its type, each TP has its own network of DCs, through which POCs receive the drugs.…”
Section: Literature Reviewmentioning
confidence: 99%
“…For instance, EDI 852 contains inventory, product stocking, and product movement records from the trade partners' distribution centers to the manufacturer (Xu et al. 2018). However, there has been a “lack of new models for increasing forecasting intelligence" (Merkuryeva et al.…”
Section: Introductionmentioning
confidence: 99%